Personalised prevention of sudden cardiac death: from analysis of existing data to large trials
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847999.
Only a minority of post-MI patients with left ventricular ejection fraction (LVEF) ≤ 35% that currently receive prophylactic implantable cardioverter defibrillator (ICD) will ever need the device – others are only exposed to potentially severe complications due to the implantation.
Patients with LVEF > 35% are not eligible for ICD implantation – in absolute numbers, the majority of deaths due to sudden cardiac death (SCD) occur in exactly this group.
Comparison of a personalised decision on ICD implantation based on the individual risk for the whole spectrum of post-MI patients.